Sign In
Buy RGEN
$121.73
+0.600 (+0.495%)
At Close: Jun 03, 2026
What's in the Cards for Sesen Bio's (SESN) Q2 Earnings?
04:00pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Sesen Bio's (SESN) Q2 performance is likely to reflect cost savings from the company's restructuring plans as the company continues to seek a potential partner for the further development of Vicineum.
Will Deciphera Pharmaceuticals, Inc. (DCPH) Report Negative Q2 Earnings? What You Should Know
02:01pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
Deciphera Pharmaceuticals, Inc. (DCPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What to Expect From Molina Healthcare's (MOH) Q2 Earnings?
03:35pm, Monday, 25'th Jul 2022 Zacks Investment Research
Molina Healthcare's (MOH) second-quarter results are likely to reflect benefits from higher premiums stemming from Medicaid and Medicare businesses, partly offset by elevated medical care costs.
Repligen (RGEN) Stock Jumps 15.3%: Will It Continue to Soar?
01:06pm, Friday, 22'nd Jul 2022 Zacks Investment Research
Repligen (RGEN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ro
Tesla, Danaher And Some Other Big Gainers From Yesterday
09:40am, Friday, 22'nd Jul 2022 Benzinga
U.S. stocks closed higher on Thursday, with the Nasdaq Composite jumping around 1.4%. Here is the list of some big stocks recording gains in the previous session.
Tabula Rasa HealthCare, Inc. (NASDAQ
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
09:04am, Friday, 22'nd Jul 2022 Benzinga
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up peri
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session
04:33pm, Thursday, 21'st Jul 2022 Benzinga
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days endin
Here's How Universal Health (UHS) Looks Ahead of Q2 Earnings
04:29pm, Wednesday, 20'th Jul 2022 Zacks Investment Research
Universal Health's (UHS) second-quarter results are likely to benefit from sound contributions from Acute Care Hospital Services segment. Increased labor costs might partly hurt results.
Repligen to Report Second Quarter 2022 Financial Results
07:30am, Tuesday, 19'th Jul 2022
Webcast and Conference Call to Be Held Tuesday, August 2, 2022 at 8:30 a.m. EDT Webcast and Conference Call to Be Held Tuesday, August 2, 2022 at 8:30 a.m. EDT
Repligen (RGEN) Up 3.6% Since Last Earnings Report: Can It Continue?
01:34pm, Friday, 27'th May 2022
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock?
Repligen Corporation to Present at Upcoming Investor Conferences
07:30am, Wednesday, 25'th May 2022
WALTHAM, Mass., May 25, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participati
Will Repligen's (RGEN) COVID Woes Be Offset by Product Demand?
11:17am, Monday, 16'th May 2022
The declining pace of COVID-19 vaccination programs is likely to hurt Repligen's (RGEN) revenue growth rate in 2022. However, the strong core business is likely to offer a respite.
Revisiting Repligen
11:31am, Wednesday, 11'th May 2022
Last summer I first covered Repligen, a company that develops tools and services for manufacturing biologics. While bad timing in regards to short-term performance, I reiterate my Strong Buy view of t
Repligen (RGEN) Q1 Earnings and Sales Beat Estimates, Stock Up
06:53pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Repligen (RGEN) reports encouraging first-quarter results with both sales and earnings beating estimates. RGEN also reduced its financial guidance for 2022
Repligen (RGEN) Q1 Earnings and Sales Beat Estimates, Stock Up
04:35pm, Thursday, 28'th Apr 2022
Repligen (RGEN) reports encouraging first-quarter results with both sales and earnings beating estimates. RGEN also reduced its financial guidance for 2022
